PRKN and cervical carcinoma: Specifically, PTPN11 facilitates cervical cancer cell proliferation by suppressing interferon-β (IFN-β) production and restricts chemotherapeutic drug-induced apoptosis of cervical cancer cells through Parkin-dependent autophagy (74, 75).